Navigation Links
DOE JGI releases a new version of its metagenome data management and analysis system
Date:2/8/2008

WALNUT CREEK, CA--Targeting its ever-expanding user community, the U.S. Department of Energy Joint Genome Institute (DOE JGI) has released an upgraded version of the IMG/M metagenome data management and analysis system, accessible to the public at http://img.jgi.doe.gov/m.

IMG/M provides tools for analyzing the functional capability of microbial communities based on their metagenome DNA sequence in the context of reference isolate genomes. The new version of IMG/M includes five additional metagenome datasets generated from microbial community samples that were the subject of recently published studies. These include the metagenomic and functional analysis of termite hindgut microbiota (Nature 450, 560-565, 22 November 2007) and the single cell genetic analysis of TM7, a rare and uncultivated microbe from the human mouth (PNAS, July 17, 2007, vol. 104, no. 29, 11889-11894).

"IMG/M is a fantastic tool that is incredibly helpful in understanding our data," said Stephen Quake, Co-Chair, Department of Bioengineering at Stanford University, Investigator, Howard Hughes Medical Institute, and senior author on the PNAS study. "We used IMG/M in numerous ways, both to analyze our data and to understand general properties of other relevant bacterial genomes. I look forward to analyzing our new datasets with IMG/M."

IMG/M will be demonstrated at a workshop on March 26 as part of the DOE JGI Third Annual User Meeting. IMG/M contains all isolate genomes in version 2.4 of DOE JGI's Integrated Microbial Genomes (IMG) system, which represents an increase of 1,339 reference genomes from the previous version of IMG/M. Now, IMG/M contains 2,953 isolate genomes consisting of 819 bacterial, 50 archaeal, 40 eukaryotic genomes, and 2,044 viruses.

IMG/M provides new tools for analyzing metagenome datasets in the context of reference isolate genomes, such as the Reference Genome Context Viewer and Protein Recru
'/>"/>

Contact: David Gilbert
degilbert@lbl.gov
925-296-5643
DOE/Joint Genome Institute
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. Toxic releases down from North American industry leaders, increasing from other facilities
2. University of Minnesota releases first ever comprehensive report of the health of college students
3. WHRC releases 4 key reports
4. DOE JGI releases soybean genome assembly to enable worldwide bioenergy research efforts
5. Central targets may hinder wider waste management objectives
6. Upgraded IMG 2.3 Data Management System released by DOE JGI to eager user community
7. Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management
8. Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management
9. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
10. Mosaic Intelligent Video Management System: Video Surveillance Just Got Smarter
11. Secure Services Corp. Achieves Milestone in United States Identity Protection with the Launch of the SSC SHAPE Card Management Solution

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...IDGE, Mass. (November 26, 2009) Whitehead researc...or human cells to pinpoint specific genes and prot...n Science . , In most human cell cultures genes... father and one from the mother. Gene inactivation... one copy is inactivated, the second copy usually ...
(Date:11/26/2009)...(methicillin-resistant Staphylococcus Aureus ) an...ation as low-temperature plasma prototype devices ... unfailing bactericidal cocktails. , Two prototy...disinfection of healthy skin (e.g. hands and feet)... pose a lethal threat; and another to shoot bacter...
(Date:11/25/2009)...in, a hormone produced in the stomach, may be used...of Parkinson,s disease, Yale School of Medicine re...issue of the Journal of Neuroscience . , Parkin...ine neurons in an area of the midbrain known as th...ine production. Reduced production of dopamine in...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 1Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 2Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 3Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 4Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 5Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 6Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 7Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 8Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 9Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 10Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 11Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 12Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 13Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 14Retail Health Clinics The Real Story 59443 1Retail Health Clinics The Real Story 59443 2Pajama Program Launches 2009 2010 Awareness 26amp 3B Fundraising Campaign 3A A BETTER BEDTIME 59441 1Pajama Program Launches 2009 2010 Awareness 26amp 3B Fundraising Campaign 3A A BETTER BEDTIME 59441 2Pajama Program Launches 2009 2010 Awareness 26amp 3B Fundraising Campaign 3A A BETTER BEDTIME 59441 3Pajama Program Launches 2009 2010 Awareness 26amp 3B Fundraising Campaign 3A A BETTER BEDTIME 59441 4
...European Lung Cancer Conference, jointly organized...O) and the International Association for the Study...hlight emerging evidence that common viruses may c...xperts agree that smoking is by far the most impor...pment. But other factors can play a role in some c...
...ngs the first signs of harmful algae in New Englan...s Hole Oceanographic Institution (WHOI) and North ... for a potentially big bloom. , A combination of...ecipitation have set the stage for a harmful algal...ccording to researchers from WHOI and NC State. Th...
...medical issues is the development of techniques th... published on April 24, 2008 in the journal Vaccin...b, Inc. has proposed a new technology for anti-vir...jor elements. First, each vaccine antigen should b...n the organisms cells by an intracellular chopping...
Other Biology News:Viruses may play a role in lung cancer development 2In computer models and observations, researchers see potential for significant 'red tide' season 2In computer models and observations, researchers see potential for significant 'red tide' season 3New technology for boosting vaccine efficiency 2New technology for boosting vaccine efficiency 3
(Date:11/30/2009)...0 Novavax, Inc. (Nasdaq:...ed today that the company will be presenting at th...ber 2, 2009 at 12:30 pm local time at The New York...ew of the company,s business strategy, research an... link to the live audio only presentation can be a...
(Date:11/30/2009)...wire/ -- Dr. Jessica Torrente, Assistant Professor...cal Center in Washington, D.C., demonstrated the i...g (BSGI) in clinical practice as an adjunct imagin...y at the annual meeting of the Radiological Societ...he exhibit was to demonstrate how BSGI is used in ...
(Date:11/30/2009)... BioMarin Pharmaceutical ...d and Drug Administration (FDA) has granted orphan...), amifampridine phosphate, for the rare autoimmun.... 3,4-DAP has previously received orphan drug des...ommittee for Medicinal Products for Human Use of t...
(Date:11/30/2009)..., Nov. 30 Exiqon A/S (NASDAQ OMX C... Medical School ICCB-Longwood Screening Facility (...g Center of Excellence. ICCB-L supports investiga...pitals and institutions, for high-throughput scree...icroRNAs are a novel class of small, non-coding RN...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3
...team including scientists from the London Centre f...n the journal Proceedings of the National Academy ...cts of quantum mechanics in a simple magnet. The i...onventional tool of material science neutron beam...actors can be used to produce images of the ghost...
...24 New Brunswick,Scientific Co., Inc. ("NBS") (Na...nnounced today the completion of the previously an...ired NBS for approximately $110,million in an all-... was,approved by NBS, shareholders at a special me...entitled to receive $11.50 per share in cash. NBS...
... to Advance Biologics Strategy Through Targeted ...CETON, N.J. and WALTHAM, Mass., Sept. 24 ,Bristol-... Therapeutics,announced today the companies have s...yers Squibb will acquire privately held Adnexus,Th...f biologics called,Adnectins(TM). The acquisition ...
Other Biology Technology:Imaging quantum entanglement 2New Brunswick Scientific Completes Merger Transaction with Eppendorf 2Bristol-Myers Squibb to Acquire Adnexus Therapeutics 2Bristol-Myers Squibb to Acquire Adnexus Therapeutics 3Bristol-Myers Squibb to Acquire Adnexus Therapeutics 4Bristol-Myers Squibb to Acquire Adnexus Therapeutics 5
Iscove's Modified Dulbecco's Medium (IMDM) from Sigma-Aldrich
Dulbecco's Modified Eagle's Medium - high glucose (DME) from Sigma-Aldrich
...r routine procedures. Hollandes contains formaldeh...l decalcify small bone specimens. Tissue that is f...ith most stains, and the cupric acetate in the sol...nophil and endocrine cell granules so that less ly...
...tograph/Mass Spectrometer, utilizing many of the h...igh throughput and excellent productivity, providi...io. Like the GCMS-QP2010 Plus, the GCMS-QP2010s fe...um separation, 20 temperature ramps, and both scan...
Biology Products: